The consortium of Biocon, Bahiafarma and Bionovis received 100% allocation under Brazil's 10-year PDP program for Pertuzumab
The company said it has submitted its manufacturing, quality-control, reconciliation and distribution records to CDSCO on 14 August 2026 to support the investigation
The company said its growing experimental throughput requires digital infrastructure capable of rapidly converting large volumes of discovery data into actionable insights
Sheth brings extensive experience across contract development and manufacturing, drug discovery services, business development and strategic partnerships
The partnership is aimed at strengthening Cipla’s biosimilar portfolio and expanding access to advanced biologic therapies for cancer patients
Both transactions will be funded through internal accruals and are expected to be completed by the end of September 2026
Under the deal, Novartis will have multiple options to secure exclusive global rights to develop subcutaneous versions of selected products using berahyaluronidase alfa (ALT-B4).
The deal will give SK Biopharmaceuticals access not only to opakalim but also to Biohaven’s Kv7 discovery platform and related compounds
The latest round brings AusperBio’s total fundraising to $360 million since 2024
The new entity to be called Ennature Bio Pharma Limited reported net revenue of Rs. 90 crore in the June 2026 quarter
With India's medical-devices market projected to reach around US$30 billion by 2030, the exhibition highlighted the growing role of domestic manufacturing alongside global technology partnerships
Belgian biotech to complete preclinical development, prepare lead candidate for GMP manufacturing and double its R&D team
Company deepens collaborations with Novo Nordisk, Sanofi and Roche while advancing its international portfolio and innovation pipeline
Partnership gives Cipla development and commercialisation rights for TQB2102 across India, South Africa and five other emerging markets
CEPI aims to advance at least two Bundibugyo vaccines toward Emergency Use Authorisation and WHO Prequalification, while building preparedness for potential future outbreaks
WISE is available as a liquid that can also be cast into moulds to create micron-scale structures, enabling applications across imaging and microstructured device workflows
Much of the existing microbiome research has focused on European and North American populations, leaving South Asia, home to nearly one-fourth of the world's population, comparatively underrepresented
The transaction also includes warrants that become exercisable upon FDA approval of the drug for pulmonary hypertension
The latest transaction takes Natco Pharma’s total investment in Cambridge, Massachusetts-based eGenesis to $22 million
Company executives outline three-pillar AI strategy, ecosystem-building through 10 centres of excellence, and long-term investment plans as India's shift toward complex biotherapeutics accelerates
Subscribe To Our Newsletter & Stay Updated
